Recent-Onset Type 1 Diabetes Extension Study Evaluating the Long-Term Safety of Teplizumab

Recent-Onset Type 1 Diabetes Extension Study Evaluating the Long-Term Safety of Teplizumab
Condition:   Type 1 Diabetes Mellitus
Interventions:   Biological: Teplizumab;   Other: Placebo
Sponsor:   Provention Bio, Inc.
Enrolling by invitation

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

August 18, 2022Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments